analytics & assays: defining mrna therapeutic impurities early & often
Published 11 months ago • 47 plays • Length 6:22Download video MP4
Download video MP3
Similar videos
-
4:46
when to conduct analytical assays in novel protein therapeutic development
-
15:54
what indications can, and will, mrna therapeutics address?
-
4:15
q&a on formulation & stability of lnps
-
33:29
critical attributes of mrna manufacturing for early phase therapeutics development
-
46:51
mastering mrna-based therapeutics analysis | biopharma 101 by sciex
-
1:00:07
process & analytical insights for gmp manufacturing of mrna-lipid nanoparticles
-
1:19
rsna 2017 - imaging utilization for mr | ge healthcare
-
41:01
lc-ms for rna therapeutics to ensure product quality and process consistency
-
4:21
workflows for assessment of rna cqas part ii workflow for assessment of 5’ capping efficiency
-
5:30
rapid screening & confirmation of analytes in biofluids using a single sample and sampling device
-
0:59
noninvasive mris effective in measuring renal blood flow
-
7:38
#umassmed_mstp rna therapeutics institute
-
49:10
pharma assay services – expert capabilities in rnascope ish assays
-
0:57
rsna 2016 - expanded xspect quant technology
-
1:33:07
p. myler - insight into leishmania biology using rna-seq analyses, lecture 2
-
58:48
jens rittscher - perils of developing quantitative methods for biomedical imaging applications
-
58:24
webinar: intro to the human pancreas analysis program (hpap): real world successful data analyses